| Added by | pcoopman |
|---|---|
| Group name | EquipePC |
| Item Type | Journal Article |
| Title | Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study |
| Creator | Fabbro et al. |
| Author | Michel Fabbro |
| Author | William Jacot |
| Author | Marta Jarlier |
| Author | Séverine Guiu |
| Author | Véronique D'Hondt |
| Author | Patrice Champoiral |
| Author | Chloé Janiszewski |
| Author | Isabelle Nicklès |
| Abstract | BACKGROUND: Acceptability and tolerance of chemotherapy on patients treated for breast cancer remain challenging. Complementary approaches such as hypnosis may have a favorable impact both at the time of announcing and during chemotherapy, due to the notorious anxiety, distress, and self-perceived dysfunction. The objective of the study was that the patients complied with at least four self-hypnosis sessions out of the six cycles of chemotherapy. METHODS: This open, prospective longitudinal study assessed feasibility of compliance to self-hypnosis during chemotherapy in an outpatients setting. Training sessions were given by a hypnotherapist. Throughout each cycle of chemotherapy, the patient had to use self-hypnosis to better control her anxiety or any difficulties. Nurses could offer help to the patient. Chemotherapy-associated side effects were evaluated through the NCI-Common Toxicity Criteria for Adverse Events v 4.03; moreover, side effects as pain, nausea, vomiting, fatigue, and anxiety were also evaluated during chemotherapy using a visual analogic scale. Health-related quality of life, emotional distress (anxiety and depression), and cancer-related fatigue were assessed (at inclusion, end of chemotherapy and 3 months later) using the EORTC QLQ-C30 and QLQ-BR23, HADS and MFI-20 questionnaires, respectively. The number of patients screened and actually included in the study was reported, as the reasons for refusal. RESULTS: Thirty-five patients were included with a median age of 55?years (35-78). All patients received a hypnosis training session. The overall compliance with self-hypnosis was 68.6% (95% CI: 50.7%-83.2%), meaning that more than two thirds of patients performed at least four sessions of self-hypnosis. According to NCI-CTCAE, Grade 2 nausea and vomiting was observed in 45.7% and 22.9%, respectively, Grade 2 fatigue in 62.9%. Based on the HADS questionnaire, anxiety increased at the end of the chemotherapy and returned to the initial value 3 months later (p = .97) whereas depression significantly decrease 3 months after the end of chemotherapy with respect to the inclusion (p = .003). Role, emotional, and cognitive functioning were slightly affected throughout the treatment, in contrast to dyspnea or physical functioning. CONCLUSION: Our study showed that self-hypnosis was feasible on patients newly diagnosed for breast cancer receiving chemotherapy. |
| Publication | Cancer Reports (Hoboken, N.J.) |
| Volume | 6 |
| Issue | 1 |
| Pages | e1732 |
| Date | 2023-01 |
| Journal Abbr | Cancer Rep (Hoboken) |
| Language | eng |
| DOI | 10.1002/cnr2.1732 |
| ISSN | 2573-8348 |
| Short Title | Hypnosis on patients treated with adjuvant chemotherapy for breast cancer |
| Library Catalog | PubMed |
| Extra | PMID: 36302744 PMCID: PMC9875600 |
| Tags | Adult, Aged, alternative medicine, breast cancer, Breast Neoplasms, Chemotherapy, Adjuvant, clinic, Fatigue, Feasibility Studies, Female, Humans, Hypnosis, Longitudinal Studies, Middle Aged, Prospective Studies, Quality of Life |
| Date Added | 2023/11/20 - 17:08:16 |
| Date Modified | 2023/11/20 - 17:12:02 |
| Notes and Attachments | PubMed entry (Attachment) Texte intégral (Attachment) |
Institut de Recherche en Cancérologie de
